book your stand - amazon web services€¦ · entering the next stage as a . global hub. for . drug...
TRANSCRIPT
Book your standgotocphi.com/japan2018Big Sight Exhibition Center, East Halls 1, 2 and 3 | Tokyo, Japan
18-20 April 2018
of CPhI Japan visitors found new partners for future collaboration*
* 2016 post show survey
10,000+pharma professionals
From 55+ Countries
5 eventsin 1 location
3 daysof business, learning &
networking opportunities
“Attending CPhI Japan was a good chance to get in contact with Japanese companies and to understand the Japanese pharma industry and trends. Our participation at CPhI Japan made us realize that the Japanese pharma market is really interesting and that’s why this year we decided to hold a speech about Data Integrity and the support we can provide regarding this matter. We are looking forward to attend this wonderful exhibition again and to exchange our experience with local Japanese companies.”Andrea SalvadoriSales Area Manager, PQE
gotocphi.com/japan2018 For more information contact: [email protected]
Facts & figuresof the 2017 show
For more on facts & figures visit www.cphi.com/japan
528 exhibitors from 26 countriesand 10,187 visitors from 56 countries!(Total number of visitors at Japan Life Science Week 2017: 19,189)
Visitor business categories
11%Trading Company
31% Pharmaceutical manufacturing/Pharmaceutical contract manufacturing
21%
37% Others
Positions - Pharmaceutical manufacturing/ Pharmaceutical contract manufacturing
Top 10 visitor countries
Fine Chemical/ API/ Intermediates Manufacturing
Positions - Fine chemical manufacturing/ Intermediate manufacturing/ API manufacturing
33%
15%
11%
9%
5%
27%
Research/Development
Quality Control/Production
Purchasing/Procurement/Logistic
Management
Marketing
Other
Primary purpose of visitLooking for new suppliers, ingredients & services 30%
Attending conferences and exhibitor presentations24%
Maintaining business relationships15%
Others3%
26%
13%
9%
7%
7%
38%
Obtaining market / product information28%
1. Japan 3. China2. South Korea 4. India
5. Taiwan 6. USA 7. Hong Kong
10. France
Research/Development
Quality Control/Production
Purchasing/Procurement/Logistic
Management
Marketing
Other
8. Germany
9. Philippines
Entering the next stage as a global hub for drug developmentJapan has joined the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme (PIC/S). This enables overseas suppliers to synchronise with Japanese pharmaceutical manufacturers regarding manufacturing and quality control. In addition, Japan’s pharmaceutical industry will become more international as well as easier for foreign suppliers to enter the Japanese market!
20
15
10
5
02005 2007 2009 2011
Over
60% by 2018
Market share of generic drugs in Japan (2005 - 2011)
Volume-based
Money-based
Reference: The Ministry of Health, Labour and Welfare Report 2013
16.8%18.7%
20.2%22.8%
5.9%6.6% 7.6% 8.8%
Japan has a high dependency rate for APIson overseas suppliers of generic drugs
Imported
of APIs are imported from outside Japan for Generic Drug
Manufacturing in Japan
51.2% - 57.8%
Top 6 API suppliers in two categories*
*Value based
1. Korea 31% 2. China 12.3% 3. Spain 9.9% 4. Italy 8.9% 5. Hungary 8.4% 6. India 7.2%
1. India 30% 2. Korea 26% 3. China 24.1% 4. Germany 9.6% 5. Italy 1.4% 6. Taiwan 1.4%
For APIs which are used without additional purification/reprocess
For APIs which required additional purification/reprocess
Key factors to choose overseas API suppliers for generic drugs manufacturing in Japan
0 20 40 60 80 100
1234
56
78
86.7%81.6%
67.7%64.6%
57.6%55.7%55.4%
42.4%
1. Meet Japan’s GMP standard2. Maintain a stable supply3. Competitive price4. Keep delivery date5. Quality control capability6. Management stability7. History with Japanese companies8. Social and political stability
Reference: The Ministry of Health, Labour and Welfare’s Generic Drug Report 2014 conducted by Mitsubishi UFJ Research and Consulting Co., Ltd.
Reference: The Ministry of Health, Labour and Welfare’s Generic Drug Report 2014 conducted by Mitsubishi UFJ Research and Consulting Co., Ltd.
Pharmaceutical Market Forecast(2017 - 2021)
2017 2018 2019 2020 2021
105
100
95
US$bnin Sales
Reference: BMI
101.
853
103.
065 10
4.07
0
105.
147
102.
016
Pharmaceutical market growth
Ageing population
Japan's ageing population will further drive demand for pharmaceutical products. By 2024, the pensionable population as a percentage of the total will grow to 30.7%, up from 25.8% in 2014.
Liberisation of Over-The-Counter medicines
The liberalisation of Over-The-Counter medicines and the allowance of sales of over-the-counter (OTC) drugs online serve to boost pharmaceutical sales. 99.8% of OTC drugs are now eligible for sale online (more than 11,000 drugs).
For more on market trends visit www.cphi.com/japan
Why Japan?
Exhibitor profile:Exhibitors at CPhI Japan are active in a range of business sectors, including:
Exhibitor profile of co-located shows:Exhibitors at ICSE, P-MEC, InnoPack, BioPh, and MEDTEC Japan are active in a range of business sectors, including:
ContractServices
Technology& Machinery
LaboratoryEquipment
Networking & learning at the showExhibitor Showcase Educate the industry about your products, services, new launches, innovations and news during a 30 minute presentation attended by visitors, press and fellow exhibitors. Create a buzz around your news at the show and benefit: • Maximise exposure before, during and after the event• Drive attendees to your stand• Generate new leads
Seminars Seminars on trending industry topics give valuable insight into the Japanese pharma industry. As the industry is undergoing change, be sure to attend and gain competitive advantage. Seminars in 2017 included sessions by the Ministry of Health, Labour and Welfare, leading international and domestic pharmaceutical companies and prestigious universities.
Business Matchmaking Programme The “Business Matchmaking Programme” is a gateway for exhibitors to meet potential buyers. Exhibitors can find visitor enquiries on products or services they are looking for. You can contact the visitors whom you are interested in by making appointments. All exhibitors are welcome to participate FREE of charge!
Innovation GalleryThe Innovation Gallery is a platform where exhibitors can showcase their most exciting new products.Visitors can visit it for free and educate themselves about your latest pharmaceutical innovations.
CPhI Online Enhance online exposure of your company and products on CPhI Online. Stay connected with buyers before and after the show. With 42,000+ unique visitors per month, CPhI Online is a pharma sourcing directory that allows you to:• Generate leads• Increase brand awareness• Stay updated on pharma industry news and trends
Visitors’ top 3 job positions
36%
As an integrated pharma company, CPhI Japan is an important and effective platform for us to meet existing and newpartners. Moreover the event has raised our profileand brand awareness.
Silke OeschgerMarketing and Communication ManagerDr. Reddy’s Laboratories Ltd.
“ “Packaging,
Drug delivery
Biopharmaceuticals
Non-Management Chugai, Otsuka, Nichi-Iko, Eisai, Otsuka
Ingredients Finished Formulation
gotocphi.com/japan2018 For more information contact: [email protected]
Visitors’ purchasing power
62%
of all attendeeshas purchasing power
%39Management Shionogi, Mitsubishi Pharma. Teijin,Taisho, Pfizer Japan
%18CEO/Chairman/Vice President/Director Takeda, Astellas, Daiichi Sankyo, Mochida, Kyowa Hakko